Abstract 4103: Feasibility and efficacy of a functional precision medicine approach in the management of relapsed/refractory childhood cancers Article

Acanda de la Rocha, Arlet Maria, Fader, Maggie, Coats, Ebony et al. (2022). Abstract 4103: Feasibility and efficacy of a functional precision medicine approach in the management of relapsed/refractory childhood cancers . CANCER RESEARCH, 82(12_Supplement), 4103-4103. 10.1158/1538-7445.am2022-4103

cited authors

  • Acanda de la Rocha, Arlet Maria; Fader, Maggie; Coats, Ebony; Dunn, Joseph; Perez, Leat; Saghira, Cima; Sotto, Ileana; Khatib, Ziad; Maher, Ossama; Abdella, Haneen; Andrade-Feraud, Cristina M; Jacome, Alexa; Rimblas, Lilliam; Espinal, Paula S; Guilarte, Tomás R; McCafferty-Fernandez, Jennifer; Salyakina, Daria; Azzam, Diana J

authors

publication date

  • June 15, 2022

published in

keywords

  • 3 Good Health and Well Being
  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 4.2 Evaluation of markers and technologies
  • 5.1 Pharmaceuticals
  • 6.1 Pharmaceuticals
  • Biotechnology
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Cancer Genomics
  • Childhood Leukemia
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Genetics
  • Hematology
  • Human Genome
  • Minority Health
  • Neurosciences
  • Orphan Drug
  • Pediatric
  • Pediatric Cancer
  • Precision Medicine
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Association for Cancer Research (AACR)

start page

  • 4103

end page

  • 4103

volume

  • 82

issue

  • 12_Supplement